In a CME session through your local dermatology society, a prominent drug company provides journal articles documenting the off-label use of one of their prescription pharmaceutical agents. You obtain CME credits, read the journal article and begin prescribing the off-label medication. Is the drug company in violation of the U.S. Food and Drug Administration (FDA) rulings? Are your actions acceptable?
A JAMA Dermatology study raises the possibility of adopting the NASH FibroSure test to detect hepatic fibrosis in psoriasis patients and minimize the number of liver biopsies.
The need for clear images of cutaneous conditions is more critical in dermatology than perhaps any other specialty. In this article, we feature the photography of Dr. Justin Finch who leads the clinical photography program in dermatology at the University of Connecticut Health Center in Farmington, Conn. Dr. Finch shares his photography tips in this “How To” guide.
PeDRA and NSP authors new consensus statement for pediatric psoriasis. Interdisciplinary care (dermatologist and pediatricians) is critical. Regular screening for common comorbidities is recommended.
